Zafrens, a San Diego, CA-based biotech drug discovery firm, added imec.xpand to its Collection A syndicate, bringing the full capital raised to USD 31m.
imec.xpand was joined by present buyers Prime Movers Lab, Kofa Healthcare, and World Mind on this financing.
Led by Swamy Vijayan, CEO, Zafrens supplies a platform that enables scientists to create and check lots of of 1000’s of potential medicines in a single experiment.
The corporate has already demonstrated the worth of its platform by collaborations with a number of pharmaceutical corporations, specializing in a number of lessons of medication.
The brand new funding will allow Zafrens to increase its capability and have interaction in further partnerships with pharmaceutical corporations worldwide.
FinSMEs
04/02/2025
